- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07597980
Lifestyle Intervention to Improve Muscle Function in Older Adults
May 14, 2026 updated by: Candida Rebello, Pennington Biomedical Research Center
The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance.
The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise.
The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise.
Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week.
Pre and post-intervention, body composition, physical function, and energy deficit will be measured.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity.
A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge.
This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake.
The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group).
The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Candida J Rebello, PhD, RD
- Phone Number: 12257633159
- Email: Candida.Rebello@pbrc.edu
Study Contact Backup
- Name: Reilly Roberts A Project Manager, MS
- Phone Number: 225-763-2854
- Email: candidajoan@hotmail.com
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
Contact:
- Candida J Rebello, PhD, RD
- Phone Number: 225-763-3159
- Email: Candida.Rebello@pbrc.edu
-
Contact:
- Reilly Roberts A Project Manager, MS
- Phone Number: 225-763-2854
- Email: Reilly.Roberts@pbrc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age > 50 years.
- Body mass index (BMI) ≥ 30 kg/m2.
- Homeostatic model assessment of insulin resistance ≥ 3.
- Mini-Mental State Examination (MMSE) > 25.
- Geriatric Depression Scale-15 (GDS-15) < 9.
- Sedentary (less than 90 minutes/week of moderate to vigorous activity).
- Ability to provide written informed consent.
Exclusion Criteria:
- Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
- Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
- Fluctuation in body weight > 3 kg in the preceding two months
- Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Structured nutrition plan + exercise
Intervention: Participants receive a structured nutrition plan, and exercise under supervision.
|
Participants will receive a structured nutrition plan.
The exercise intervention will be the same in both groups.
|
|
Active Comparator: Typical or usual diet + exercise
Participants receive a typical or usual diet, and exercise under supervision
|
Participants will receive a diet representing the usual diet in this population.
The exercise intervention will be the same in both groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fat mass
Time Frame: Change from baseline to 12 weeks
|
Fat mass measured by dual X-ray absorptiometry
|
Change from baseline to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skeletal muscle mass
Time Frame: Change in from baseline to 12 weeks
|
Skeletal muscle mass will be measured by the creatine methyl D-3 dilution method
|
Change in from baseline to 12 weeks
|
|
Short physical performance battery
Time Frame: Change from baseline to 12 weeks
|
A test of physical function
|
Change from baseline to 12 weeks
|
|
Hand-grip strength
Time Frame: Change from baseline to 12 weeks
|
Hand grip strength will be measured using a hand dynamometer
|
Change from baseline to 12 weeks
|
|
Knee strength
Time Frame: Change from baseline to12 weeks
|
Knee strength will be measured quantified using Biodex dynamometry
|
Change from baseline to12 weeks
|
|
Energy stores
Time Frame: 12 weeks
|
Change in energy stores/day (kcal) determined from measures of body composition using the energy balance method
|
12 weeks
|
|
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
|
Blood concentrations of glucagon-like peptide 1
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
|
Blood concentrations of gastric inhibitory peptide
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
|
Blood concentrations of cortisol
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
|
Blood concentrations of leptin
|
Change from baseline to 12 weeks
|
|
Cardiorespiratory fitness
Time Frame: Change in VO2max from baseline to 12 weeks
|
VO2max
|
Change in VO2max from baseline to 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Candida J Rebello, PhD, RD, Pennington Biomedical Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Study Registration Dates
First Submitted
May 8, 2026
First Submitted That Met QC Criteria
May 14, 2026
First Posted (Actual)
May 20, 2026
Study Record Updates
Last Update Posted (Actual)
May 20, 2026
Last Update Submitted That Met QC Criteria
May 14, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC-2025-060
- 1R01AG092725-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
At this time, we do not have plans to share IPD.
We may consider it after the study results have been publicly disseminated
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition
-
Efforia, IncRecruiting
-
Dynamical Business and Science Society - DBSS International...Universidad de Córdoba; CES University; ARTHROS Centro de Fisioterapia y EjercicioRecruiting
-
Nova Southeastern UniversityCompleted
-
Centro Universitario de Ciencias de la Salud, MexicoCompleted
-
University of Southern CaliforniaCompleted
-
University of California, San FranciscoHologic, Inc.Completed
-
University of SurreyUnknownBody Composition
-
Texas Woman's UniversityCompleted
-
Muğla Sıtkı Koçman UniversityBahçeşehir UniversityCompleted
-
University of Southern CaliforniaCompleted
Clinical Trials on Structured nutrition plan + exercise
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Dairy Farmers of Canada; Agriculture...CompletedPregnancy Complications | Weight GainCanada
-
University of AlicanteCompletedQuality of Life | Celiac Disease | Exercise | Body Composition | Diet, Gluten-Free | Resistance TrainingSpain
-
University of CopenhagenUniversity of Parma; Fundació Eurecat; ONMI; Simple Feast; AlimentómicaCompletedObesity | Overweight | Metabolic SyndromeDenmark
-
University of UtahOhio State UniversityActive, not recruitingStructured Interview | Narrative Assessment | Safety Plan | Crisis Response PlanUnited States
-
Wake Forest University Health SciencesNational Institute on Aging (NIA); Health Resources and Services Administration...Recruiting
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Catala de SalutUnknownChronic Obstructive Pulmonary DiseaseSpain
-
Helse Nord-Trøndelag HFNorwegian University of Science and TechnologyCompletedHypoglycemia | Obesity, MorbidNorway
-
Universidade Nova de LisboaUnknownType 2 DiabetesPortugal
-
Institute of Health Information and Statistics...Brno University Hospital; University Hospital Olomouc; Tomáš Baťa Regional Hospital... and other collaboratorsRecruiting
-
Joslin Diabetes CenterMetagenics, Inc.CompletedObesity | Type 2 DiabetesUnited States